BioSante Pharmaceuticals, Inc. Company Profile
BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante’s lead products include LibiGel® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD) which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) Special Protocol Assessment, and Elestrin™ (estradiol gel) for the treatment of moderate-to-severe vasomotor symptoms associated with menopause, which is marketed in the U.S. by Azur Pharma, BioSante’s licensee. BioSante also is developing a portfolio of cancer vaccines (GVAX), three of which have been granted orphan drug designation, and are currently in several Phase II clinical trials. Other products in development are Bio-T-Gel™, a testosterone gel for male hypogonadism, licensed to Teva Pharmaceuticals and an oral contraceptive in Phase II clinical development using BioSante patented technology. The company also is developing its calcium phosphate technology (CaP) for aesthetic medicine (BioLook™), as a vaccine adjuvant, including for an H1N1 (swine flu) vaccine, and drug delivery as well as seeking opportunities for its 2A/Furin and other technologies. Additional information is available online at: www.biosantepharma.com.
News Articles
BioSante, ANI Pharmaceuticals ink merger
Lincolnshire, Ill.-based BioSante Pharmaceuticals and ANI Pharmaceuticals, a fully integrated specialty branded and generic pharmaceutical company of Baudette, Minn., have entered into a definitive me...
BioSante will merge with ANI Pharma in stock deal
BioSante Pharmaceuticals Inc. said Thursday it will merge with ANI Pharmaceuticals in an all-stock deal worth about $94 million.BioSante has spent years developing LibiGel, a testosterone gel intende...
BioSante Recommends Stockholders Vote For Proposed Merger With ANI Pharma
WASHINGTON (dpa-AFX) - BioSante Pharmaceuticals, Inc. (BPAX) sent a letter to stockholders recommending that stockholders vote 'FOR' the proposed merger with ANI Pharmaceuticals Inc. The BioSante ...
BioSante sells GVAX vaccines to Aduro BioTech
Aduro BioTech agreed to pay $1 million upfront to purchase BioSante Pharmaceuticals' GVAX assets, including vaccines, cell li -More-
BioSante Pharma and ANI Pharma amend merger terms
USA-based BioSante Pharmaceuticals, Inc. (Nasdaq: BPAX) and privately-held specialty and generic drugmaker ANI Pharmaceuticals said Friday (April 12) that they have entered into a new merger agreement...
BioSante and ANI Pharma agree all-stock merger
USA-based BioSante Pharmaceuticals (Nasdaq: BPAX) and privately-held specialty and generic drugmaker ANI Pharmaceuticals have entered into a definitive all-stock merger agreement. The transaction has...
BioSante Execs Use Failed Libigel To Keep Paychecks Rolling In
P/>LINCOLNSHIRE, Ill. (TheStreet) --Let's be honest about BioSante Pharmaceuticals' plan to start two, new phase III clinical trials of Libigel for female sexual dysfunction. This has very little to d...
BioSante Pharmaceuticals, Inc. Reports First Quarter Financial Results
BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today reported on its cash balance as of March 31, 2013 and financial results for the quarter ended March 31, 2013. A...
Drugs and Medications
None
PubMed Articles
None
Clinical Trials
None
Companies
BioSante Pharmaceuticals, Inc. and ANI Pharmaceuticals, Inc.
BioSante’s corporate strategy is to develop high value medically-needed pharmaceutical products and to implement strategic alternatives with respect to its products and its c...
BioSante Pharmaceuticals, Inc.
BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante’s lead products include LibiGel® (transdermal...
Cold Genesys Incorporated is a privately held biopharmaceutical company that is focused on delivering innovative conditionally replicative (Rb pathway defective molecule E2...
Blue Chip Marketing Worldwide (www.bluechipmarketingworldwide.com), this year celebrating its 30th anniversary, is an independent, full-service global marketing agency that delive...
Ceregene, Inc. is a San Diego-based biotechnology company focused on the delivery of neurotrophic (or nervous system growth) factors for the treatment of neurodegenerative and retinal disorders using...
More Information about "BioSante Pharmaceuticals, Inc." on BioPortfolio
We have published hundreds of BioSante Pharmaceuticals, Inc. news stories on BioPortfolio along with dozens of BioSante Pharmaceuticals, Inc. Clinical Trials and PubMed Articles about BioSante Pharmaceuticals, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioSante Pharmaceuticals, Inc. Companies in our database. You can also find out about relevant BioSante Pharmaceuticals, Inc. Drugs and Medications on this site too.
